News Detail

Why SiTime Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket

Benzinga · 08/06 08:55

Listen to the news

Shares of SiTime Corp (NASDAQ:SITM) rose sharply in pre-market trading after the company reported better-than-expected second-quarter financial results.

SiTime reported quarterly earnings of $2.34 per share which beat the analyst consensus estimate of $1.95 per share. The company reported quarterly sales of $157.432 million which beat the analyst consensus estimate of $146.377 million.

SiTime shares jumped 30.7% to $710.01 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

Clearone Inc (NASDAQ:CLRO) gained 92.8% to $7.10 in pre-market trading following a Securities and Exchange Commission filing that revealed fresh progress on its planned merger with clinical-stage biopharmaceutical company Vivani Medical, Inc.‘s Cortigent, Inc. unit.
Wing Yip Food Holdings Group (NASDAQ:WYHG) rose 70.3% to $5.69 in pre-market trading after declining over 4% on Wednesday.
Surgepays Inc (NASDAQ:SURG) rose 64.3% to $0.37 in pre-market trading following the announcement of the formation of Redline Wireless Group, LLC, a Wyoming-based joint venture targeting prepaid wireless distribution.
Paranovus Entertainment Technology Ltd (NASDAQ:PAVS) rose 34% to $6.58 in pre-market trading following a Securities and Exchange Commission filing confirming Paranovus closed its acquisition of the athletic wear brand Heyviva from Jabanero Inc.
Mangoceuticals Inc (NASDAQ:MGRX) gained 29.3% to $0.55 in pre-market trading following news that Nuclea Energy USA Inc., a subsidiary of Mangoceuticals’ merger partner Nuclea Energy Inc., signed a memorandum of understanding with Utah’s Office of Energy Development.
Creative Medical Technology Holdings Inc (NASDAQ:CELZ) rose 28.1% to $0.86 in pre-market trading after the company announced it has received a Notice of Allowance for a US patent titled “SUPPRESSION OF DIABETES USING EXOSOMES FROM STEM CELL PROGRAMMED MYELOID CELLS”.
SoundHound AI Inc (NASDAQ:SOUN) gained 23.1% to $7.91 in pre-market trading after the company reported better-than-expected second-quarter financial results and raised its FY26 sales guidance with its midpoint above estimates.
WPP plc (NYSE:WPP) rose 22.6% to $25.31 in pre-market trading.
Honest Company Inc (NASDAQ:HNST) shares gained 18.2% to $4.55 in pre-market trading following stronger-than-expected second-quarter results.

Losers

Yxt Com Group Holding (NASDAQ:YXT) tumbled 49% to $11.95 in pre-market trading after surging 801% on Wednesday.
ThredUp Inc (NASDAQ:TDUP) declined 30% to $4.40 in pre-market trading after the company reported worse-than-expected second-quarter EPS results and lowered its FY2026 sales guidance below estimates.
Next Technology Holding Inc (NASDAQ:NXTT) fell 28.6% to $0.066 in pre-market trading after the company announced a 100-for-1 reverse stock split.
Recon Technology Ltd (NASDAQ:RCON) fell 28.4% to $0.046 in pre-market trading after dipping 85% on Thursday. Recon Technology recently announced a $100 million “at-the-market” equity offering program.
Context Therapeutics Inc (NASDAQ:CNTX) fell 27.2% to $0.50 in pre-market trading after the company reported its second-quarter financial results.
Zhengye Biotechnology Holding Ltd (NASDAQ:ZYBT) fell 25.3% to $1.76 in pre-market trading after gaining 84% on Wednesday.
HubSpot Inc (NYSE:HUBS) fell 24.7% to $188.50 in pre-market trading after the company after the company reported second-quarter financial results and issued third-quarter guidance below estimates.
LegalZoom.com Inc (NASDAQ:LZ) fell 23% to $6.24 in pre-market trading after the company reported worse-than-expected second-quarter sales results and lowered its FY2026 sales guidance below estimates.
Akebia Therapeutics Inc (NASDAQ:AKBA) fell 23% to $0.99 in pre-market trading after the company reported second-quarter results.
Fluence Energy Inc (NASDAQ:FLNC) fell 19% to $11.53 in pre-market trading after the company reported worse-than-expected third-quarter financial results and cut its FY26 sales guidance below estimates.

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.

What's Trending

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.